chapter
show
presenc
tissuetyp
plasminogen
activ
tpa
urokinasetyp
plasminogen
activ
upa
plasminogen
activ
nasal
mucosa
suggest
tpa
synthes
mucou
cell
promptli
secret
modifi
wateri
nasal
discharg
allerg
rhiniti
upa
activ
may
help
passag
larg
amount
rhinorrhea
reduc
viscos
furthermor
clarifi
relat
fibrinolyt
compon
patholog
allergi
particularli
develop
nasal
allergi
nasal
tissu
chang
wildtyp
wt
mice
develop
nasal
allergi
ovalbumin
ova
sensit
mice
pait
product
specif
immunoglobulin
iggl
ige
serum
product
interleukin
splenocyt
cultur
supernat
increas
significantli
wtova
mice
pail
mice
reaction
absent
specif
serum
interferoni
splenocyt
cultur
medium
increas
significantli
histopatholog
mark
goblet
cell
hyperplasia
eosinophil
infiltr
nasal
mucosa
wtova
mice
absent
pail
mice
result
indic
immun
respons
wtova
mice
classifi
domin
respons
would
promot
collagen
deposit
contrast
respons
pail
mice
downregul
immun
respons
shift
reaction
thldomin
one
taken
togeth
find
suggest
play
import
role
thrombolysi
also
immun
respons
fibrinolyt
system
associ
intravascular
fibrinolysi
also
variou
reaction
tissu
includ
ovul
arteri
sclerosi
cell
migrat
keratinocyt
smooth
muscl
cell
neovascular
consid
report
action
fibrinolyt
compon
variou
tissu
thought
fibrinolyt
compon
act
variou
kind
physiolog
function
relat
inflammatori
reaction
cellular
infiltr
tissu
remodel
although
effect
fibrinolyt
compon
variou
tissu
elucid
action
import
fibrinolyt
compon
nasal
mucosa
bare
review
date
oh
et
al
report
upregul
plasminogen
activ
synthesi
occur
lung
bronchoalveolar
lavag
fluid
ovalbumin
ova
challeng
murin
asthma
model
promot
extracellular
matrix
ecm
deposit
airway
inhibit
activ
matrix
metalloproteinas
mmp
plasmin
gener
addit
gyetko
et
al
report
fibrinolyt
compon
influenc
cytokin
product
play
constant
role
immun
respons
base
report
suggest
fibrinolyt
compon
act
diseas
format
tissu
chang
greatli
inflamm
nasal
mucosa
particularli
allerg
rhiniti
late
year
increas
morbid
individu
allerg
rhiniti
includ
pouinosi
becom
seriou
social
issu
au
world
furthermor
import
problem
clinic
allerg
rhiniti
difficult
cure
mechan
auergic
rhiniti
explain
simpl
type
auergi
suggest
auergic
rhiniti
complic
process
inflamm
begin
sensit
becom
chronic
caus
tissu
chang
fig
chapter
describ
involv
fibrinolyt
compon
serial
auergic
reaction
especi
allerg
rhiniti
present
data
knockout
mous
concern
fibrinolyt
compon
presenc
fibrinolyt
compon
nasal
mucosa
identifi
revers
transcript
polymeras
chain
reaction
rtpcr
situ
hybrid
immunohistochem
stain
shown
express
chang
presenc
allerg
inflamm
tabl
tpa
constitut
detect
epithelium
nasal
mucosa
express
almost
constant
attenu
tendenc
allerg
state
particularli
express
upa
mrna
significantli
high
allerg
nasal
mucosa
comparison
normal
mucosa
larsen
et
al
determin
tpa
upa
activ
nasal
polyp
control
nasal
mucosa
indic
shift
toward
higher
upatpa
activ
ratio
higher
level
upa
nasal
polyp
suggest
inflammatori
process
therefor
suggest
upa
activ
similar
allerg
rhiniti
upa
involv
biolog
process
tissu
remodeung
cell
migrat
tissu
allerg
rhiniti
nasal
polyp
includ
tissu
chang
remodel
infiltr
eosinophil
lymphocyt
hand
consid
upa
inactiv
form
complex
express
serou
cell
may
increas
regul
upa
activ
previou
studi
immunohistochem
stain
tpa
neg
submucos
gland
presenc
tpa
mrna
note
mucin
cell
presenc
allerg
nasal
mucosa
wherea
detect
mucin
cell
normal
nasal
mucosa
result
indic
tpa
produc
mucin
cell
secret
promptli
nasal
caviti
allerg
rhiniti
furthermor
report
upa
express
note
normal
nasal
mucosa
compar
allerg
nasal
mucosa
littl
fibrinautographi
nasal
discharg
upa
markedli
detect
allerg
patient
akerlund
et
al
measur
fibrinogen
nasal
discharg
report
increas
presenc
viral
upper
respiratori
inflamm
suppos
fibrinolyt
peptid
gener
particip
inflammatori
defens
process
nasal
allergi
character
larg
amount
serou
rhinorrhea
product
upa
increas
allerg
rhiniti
suggest
upa
activ
may
help
passag
larg
amount
rhinorrhea
reduc
viscos
addit
thought
tpa
act
adjunct
treat
larg
quantiti
nasal
discharg
effect
find
tpa
rapid
product
turnov
secret
allerg
nasal
mucosa
studi
normal
nasal
mucosa
tpa
mrna
appear
mucos
epithelia
tpa
activ
note
nasal
discharg
accord
fibrinautographi
thu
tpa
may
constitut
adjust
viscos
discharg
even
nonallerg
tissu
fact
plasminogen
substrat
plasminogen
activ
pa
present
nasal
discharg
without
allergi
allerg
rhiniti
interest
fibrinolyt
compon
produc
serou
cell
produc
epithelium
secretori
modal
function
distinct
fibrinolyt
compon
conceiv
function
circumferenti
tissu
promot
fibrosi
allerg
nasal
tissu
thu
also
secret
nasal
caviti
allerg
rhiniti
adjust
fluiditi
nasal
discharg
upa
increas
parallel
increas
pai
allerg
rhiniti
wherea
tpa
concentr
chang
show
tpa
upa
act
compet
allerg
rhiniti
fibrinolyt
compon
may
play
import
role
tissu
fibrosi
maintain
fluiditi
nasal
discharg
product
compon
regul
sever
cytokin
allerg
diseas
also
involv
mani
cytokin
possibl
metabol
fibrinolyt
compon
allerg
tissu
alter
influenc
cytokin
late
year
physiolog
function
tissu
fibrinolysi
cell
migrat
remodel
investig
regard
fibrinolyt
compon
fibrinolyt
compon
act
nasal
mucosa
tissu
well
nasal
discharg
allerg
diseas
said
morbid
tissu
chang
remodel
becom
import
factor
make
cure
difficult
phenomenon
remodel
studi
mainli
bronchial
asthma
character
submucos
fibrosi
deposit
ecm
goblet
cell
hyperplasia
epithelium
thought
fibrinolyt
system
involv
ecm
deposit
fibrosi
inflammatori
tissu
pa
convert
inact
proenzym
plasminogen
activ
form
plasmin
proteas
fairli
broad
substrat
specif
plasmin
degrad
fibrin
convert
inact
prommp
activ
mmp
activ
mmp
degrad
ecm
protein
includ
collagen
main
protein
compon
fibrot
tissu
airway
previou
studi
demonstr
subepitheli
deposit
collagen
type
iii
bronchial
biopsi
specimen
asthma
patient
allerg
nasal
mucosa
correl
airway
hyperrespons
clarifi
relat
fibrinolyt
compon
patholog
allergi
particularli
develop
nasal
auergi
nasal
tissu
chang
made
nasal
allergi
model
pail
mice
studi
employ
murin
model
allerg
rhiniti
induc
ovalbumin
ova
excess
amount
type
type
iii
collagen
found
nasal
mucosa
obtain
ovachalleng
wildtyp
wt
mice
system
contrast
collagen
deposit
nasal
mucosa
ovachalleng
pail
mice
appear
less
signific
ovachalleng
wt
mice
employ
wt
pait
mice
hattori
et
al
bleomycininduc
pulmonari
fibrosi
model
oh
et
al
ovainduc
asthma
model
observ
similar
effect
excess
fibrou
materi
accumul
mous
lung
tissu
addit
demonstr
wt
mice
develop
nasal
allergi
ova
pair
mice
type
allergi
includ
allerg
rhiniti
increas
serum
immunoglobulin
e
ige
characterist
immun
reaction
exposur
antigen
base
type
cytokin
helper
tcell
secret
helper
tcell
classifi
thl
type
type
immun
respons
characterist
prescrib
accord
predomin
tcell
type
mice
respons
result
iggl
ige
product
wherea
thl
respons
lead
synthesi
therefor
allerg
rhiniti
thought
result
cell
activ
significantli
increas
product
ige
iggl
low
level
wtova
mice
immun
challeng
ova
imphcat
respons
allergen
contrast
high
level
specif
iggl
ige
nearli
absent
pair
ova
mice
furthermor
pair
ova
group
show
signific
increas
level
specif
thu
result
indic
downregul
immun
respons
pait
mice
bring
inappropri
overactiv
thl
immun
respons
antigen
would
otherwis
induc
respons
consid
import
phenotyp
develop
fibrot
pulmonari
extrapulmonari
complic
possibl
phenotyp
would
promot
collagen
deposit
wt
compar
pair
mice
chang
immun
respons
pail
mice
also
confirm
cytokin
profil
nasal
lavag
fluid
local
supernat
cultur
lymphocyt
spleen
system
mice
challeng
ova
level
supernat
ovastimul
lymphocyt
cultur
wtova
mice
time
higher
pair
ova
mice
ovastimul
cell
pair
ova
mice
higher
level
interferoni
ifni
wtova
mice
tendenc
cytokin
profil
also
reflect
splenocyt
prolifer
assay
condit
mice
result
show
sensit
group
exhibit
immun
reaction
local
also
system
explain
high
level
ige
wtova
mice
high
level
would
induc
highlevel
antibodi
product
includ
ige
describ
nasal
caviti
therebi
contribut
immediatetyp
allerg
reaction
antigen
inhal
hand
highli
specif
effect
eosiophil
prohfer
migrat
activ
surviv
high
level
would
respons
infiltr
eosinophil
nasal
mucosa
hyperplasia
goblet
cell
sensit
mice
similar
tissu
chang
observ
human
allerg
rhiniti
surprisingli
paitova
mice
howev
mucos
chang
observ
histolog
data
cytokin
profil
indic
mice
defici
fail
gener
immun
respons
ova
challeng
work
serin
proteas
inhibitor
prevent
ecm
degrad
act
deadhes
molecul
detach
cell
attach
vitronectin
via
integrin
addit
deadhes
activ
requir
interact
vitronectin
howev
absolut
requir
bind
upa
free
upa
vitronectin
weak
detach
activ
loss
detach
activ
pairmic
might
explain
inhibit
cell
movement
includ
eosinophil
infiltr
detach
profil
may
chang
signal
transduct
leukocyt
celltocel
celltoligand
interact
mani
report
suggest
malign
cell
express
metastas
effici
tumor
less
product
addit
clinic
report
higher
level
plasma
due
polymorph
gene
close
relat
allerg
diseas
report
conjunct
studi
support
idea
rather
critic
regul
immun
respons
antigen
stimul
shown
allerg
rhiniti
restrain
ova
sensit
mice
immun
respons
characterist
tend
shift
reaction
thldomin
reaction
find
previou
work
demonstr
fibrinolyt
compon
includ
play
import
role
thrombolysi
proteolysi
also
immun
respons
chang
balanc
reaction
thl
reaction
thought
seem
relat
allerg
diseas
fibrinolyt
compon
therefor
relat
fibrinolyt
compon
allerg
rhiniti
littl
studi
standpoint
fibrinolysi
immunolog
allergolog
rhinolog
histori
studi
area
short
thu
mani
point
must
elucid
futur
figur
provid
inform
deriv
convent
current
knowledg
regard
mechan
fibrinolyt
factor
nasal
mucosa
moreov
may
use
fibrinolyt
compon
interven
mechan
involv
disord
nasal
mucosa
exampl
may
control
local
allerg
reaction
nasal
mucosa
use
gene
transfect
rna
interfer
rnai
although
relat
fibrinolyt
system
immun
system
still
unclear
use
studi
new
patholog
elucid
fig
hypothesi
mechan
fibrinolyt
compon
influenc
nasal
mucosa
paiy
plasminogen
activ
inhibitor
upa
tpay
urokinasetyp
tissu
plasminogen
activ
ecmi
extracellular
matrix
fdpi
fibrin
degrad
product
mmpi
metalloproteinas
tgfbi
transform
growth
factor
hgfi
hepat
growth
factor
bfgfi
basic
fibroblast
growth
factor
timpi
tissu
inhibitor
mmp
